UBS Group’s Comera Life Sciences Holdings, Inc. Common Stock CMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-8,017
| Closed | -$2.33K | – | 9059 |
|
|
2023
Q3 | $2.33K | Buy |
8,017
+6,366
| +386% | +$1.85K | ﹤0.01% | 6579 |
|
|
2023
Q2 | $804 | Sell |
1,651
-408
| -20% | -$199 | ﹤0.01% | 7008 |
|
|
2023
Q1 | $1.85K | Buy |
2,059
+826
| +67% | +$743 | ﹤0.01% | 7534 |
|
|
2022
Q4 | $1.52K | Sell |
1,233
-1,394
| -53% | -$1.72K | ﹤0.01% | 8651 |
|
|
2022
Q3 | $4K | Sell |
2,627
-535
| -17% | -$815 | ﹤0.01% | 8342 |
|
|
2022
Q2 | $8K | Buy |
+3,162
| New | +$8K | ﹤0.01% | 7359 |
|